COVID-19 Update: Point of Care Molecular Diagnostics Market to Show Tremendous Growth by 2027 | Leading Players- Agilent Technologies Inc., Abbott, F. Hoffmann-La Roche Ltd., Illumina Inc., Hologic Inc., QIAGEN, Myriad Genetics, Cepheid, Genomic Health

(CDN Newswire via Comtex)

A competition that is getting higher day by day has kept many challenges in front of the businesses. So, this global Point of Care Molecular Diagnostics Market business research report is a definite source to gain valuable market insights and take better decisions about the important business strategies. This business document endows clients with information on their business scenario with which they can build business strategies to thrive in the market. This Point of Care Molecular Diagnostics Market report also provides details about the market drivers and market restraints for industry that help in understanding rise or fall of the demand of particular product with respect to market conditions.

Flawless research studies are performed devotedly to offer an excellent business document for a niche. Market segmentation analysis carried out in this Point of Care Molecular Diagnostics Market report with respect to product type, applications, and geography is very helpful in taking any verdict about the products. The report offers a complete overview of the industry that takes into account various aspects of product definition, market segmentation, and the existing retailer landscape. A huge number of top competitors are considered in this Point of Care Molecular Diagnostics Market business document to present the insights on strategic industry analysis of the key factors influencing the market.

The Global Point of Care Molecular Diagnostics Market is estimated to rise from the value of USD 627.6 million in 2017 to an estimated value of USD 1933.2 million by 2025, registering a CAGR of 15.1% during the forecast period of 2018-2025. This growth can be attributed to the rising cases of infectious diseases, and the growing demand for approved Point of Care Molecular Diagnostic tests.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-molecular-diagnostics-market

Global Point of Care Molecular Diagnostics Market, By Product (Assays & Kits, Instruments/Analyzers, Services & Software), Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infection, Oncology, Hepatitis, Others), Technology (Polymerase Chain Reaction, In-Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others), End-User (Physician Offices, Hospitals, Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa)- Industry Trends & Forecast to 2025

Key Market Competitors:

Few of the major competitors currently working on the Point of Care Molecular Diagnostics Market are Agilent Technologies Inc., Abbott, F. Hoffmann-La Roche Ltd., Illumina Inc., Hologic Inc., QIAGEN, Myriad Genetics, Cepheid, Genomic Health, GenePOC Inc., DxNA LLC., Binx Health Inc., Spartan Bioscience Inc., Biocartis, Beckman Coulter Inc., Johnson & Johnson Services Inc., Medtronic, Siemens Healthcare GmbH, Grifols S.A., Abaxis, Bayer AG, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher, OraSure Technologies Inc., BD, Sysmex Corporation, Quidel Corporation, and Meridian Bioscience Inc.

Competitive Analysis: Global Point of Care Molecular Diagnostics Market

The Global Point of Care Molecular Diagnostics Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Point of Care Molecular Diagnostics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Definition: Global Point of Care Molecular Diagnostics Market

Point of Care Molecular Diagnostics is diagnostic equipment which is used to determine the cause of infectious disease causing agents. These machines/equipments help determine the accurate cause of these diseases in a timely manner, which is of utmost importance when dealing with these kind of diseases and also to implement the correct course of action.

The advancements and developments in the diagnostics market is attributed to the fact that the healthcare industry is focusing on detection and diagnosis in place of pharmaceuticals and medicines, to prevent the development of the diseases. This trend has directly affected the market growth and is helping the market to grow significantly.

North America had the highest revenue share of around 40% of the market.

Grab Your Report at an Impressive 30% Discount! Please click Here @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-molecular-diagnostics-market

Market Drivers:

  • Increasing cases of infectious diseases causing the health professionals to determine the infections and its causes accurately in a timely manner, thereby increasing the demand for Point of Care Molecular Diagnostics Market.
  • Increased demand for regulatory approved molecular tests driving the market

Market Restraints:

  • Approval by the authorities is a time-consuming process and therefore the innovation programs suffer because of these long term regulations
  • Research and development of these devices is very extensive and hugely resource consuming which is one of the major factors for the restraining of market expansion

Segmentation: Global Point of Care Molecular Diagnostics Market

  • By Product
    • Assays & Kits
    • Instruments/Analyzers
    • Services & Software
    • By Application
    • Respiratory Diseases
    • Sexually Transmitted Diseases
    • Hospital-acquired Infection
    • Oncology
    • Hepatitis
    • Others
  • By Technology
    • Polymerase Chain Reaction
      • Real Time Polymerase Chain Reaction
      • DNA/RNA Purification
    • In-Situ Hybridization
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Isothermal Amplification
    • Others
  • By End-User
    • Physician Offices
    • Hospitals
    • Research Institutes
    • Others

Key Developments in the Market: Global Point of Care Molecular Diagnostics Market

  • In October 2017, Abbott completed the acquisition of Alere, for USD 5.9 billion. Alere was a global leader in diagnostics market and the acquisition helps Abbott grow its market share.
  • In July 2017, Agilent Technologies announced the acquisition of Population Genetics' molecular and sample barcoding patent portfolios which help improve the accuracy of next generation sequencing (NGS). These help in the diagnostics of cancer.

Key Insights in the report:

  • The key market players are analyzed and their effects on the market is also observed
  • Market analysis is conducted for the forecast period of 2018 to 2025, and the market segmentations are observed during that period
  • The market drivers and restraints have been clearly analyzed for the effect that they have over the market in the forecast period of 2018 to 2025

Market Segmentation:-

To comprehend Global Point of Care Molecular Diagnostics market dynamics in the world mainly, the worldwide Point of Care Molecular Diagnostics market is analyzed across major global regions.

  • North America: United States, Canada, and Mexico.
  • South & Central America: Argentina, Chile, and Brazil.
  • Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.
  • Europe: UK, France, Italy, Germany, Spain, and Russia.
  • Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.

Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-point-of-care-molecular-diagnostics-market

Point of Care Molecular Diagnostics Market report effectively provides required features of the global market for the population and for the business looking people for mergers & acquisitions, making investments, new vendors or concerned in searching for the appreciated global market research facilities. It offers sample on the size, offer, and development rate of the market. The Point of Care Molecular Diagnostics report provides the complete structure and fundamental overview of the industry market.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corpo[email protected]

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at [email protected].